# FDA Inspection 992520 - Celularity, Inc. dba LifebankUSA - November 02, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/celularity-inc-dba-lifebankusa/fa5758e6-d3c1-4576-b8a0-ffd01a7a2953/
Source feed: FDA_Inspections

> FDA Inspection 992520 for Celularity, Inc. dba LifebankUSA on November 02, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992520
- Company Name: Celularity, Inc. dba LifebankUSA
- Inspection Date: 2016-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1088848 - 2019-04-29](https://www.globalkeysolutions.net/api/records/fda_inspections/celularity-inc-dba-lifebankusa/2a38eb96-d410-481e-a84f-c4d7967dcbb0/)
- [FDA Inspection 992520 - 2016-11-02](https://www.globalkeysolutions.net/api/records/fda_inspections/celularity-inc-dba-lifebankusa/3eb01360-c3c6-4bf5-8f0f-5ea1bc7e8c71/)
- [FDA Inspection 642831 - 2010-01-20](https://www.globalkeysolutions.net/api/records/fda_inspections/celularity-inc-dba-lifebankusa/b38fe124-987e-4e47-a39f-f00bf0e16994/)

Company: https://www.globalkeysolutions.net/companies/celularity-inc-dba-lifebankusa/4e6804f8-9acc-4043-946c-d23018368f97

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d